跳到正文
Longevity.Technology (@LongevityTech)· LongevityTech·· 12 天前评分15

FDA官员勾勒抗衰老疗法审批路径

At ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that longevity is a prior...

导读

在 ARDD 2026 上,FDA 高级官员勾勒出一种靶向衰老的疗法有朝一日可能如何获得批准,并透露长寿是一项优先事项。 https://vist.ly/5kqph #longevity #geroscience #FDA #aging #healthspan

来源:Longevity.Technology (@LongevityTech) · x.com